Michael J Maze
Overview
Explore the profile of Michael J Maze including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
295
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ngocho J, Liu J, Kalengo N, Kipengele A, Maro A, Mujage B, et al.
Trop Med Int Health
. 2024 Dec;
30(3):201-209.
PMID: 39739365
Background: Acute febrile illness is a common reason for seeking healthcare in low- and middle-income countries. We describe the diagnostic utility of a TaqMan Array Card (TAC) real-time polymerase chain...
2.
Bowhay T, Rubach M, Mendes A, Nicholson W, Perniciaro J, Maze M, et al.
Open Forum Infect Dis
. 2024 Dec;
11(12):ofae664.
PMID: 39691286
Background: Knowledge gaps exist on risk factors for spotted fever group rickettsioses (SFGR) in sub-Saharan Africa. We sought to identify SFGR risk factors in Kilimanjaro Region, Tanzania. Methods: We recruited...
3.
Madut D, Rubach M, Allan K, Thomas K, de Glanville W, Halliday J, et al.
J Infect Dis
. 2024 Nov;
PMID: 39535803
Background: A peri-urban outbreak of Rift Valley fever virus (RVFV) among dairy cattle from May through August 2018 in northern Tanzania was detected through testing samples from prospective livestock abortion...
4.
Taylor A, Best E, Walls T, Webb R, Bhally H, Bryce A, et al.
IJID Reg
. 2024 Aug;
12:100408.
PMID: 39185270
Objectives: This multicenter cohort study describes Aotearoa New Zealand children hospitalized during the country's first wave of sustained SARS-CoV-2 transmission, Omicron variant. Methods: Children younger than 16 years, hospitalized for...
5.
Rolfe R, Sheldon S, Kingry L, Petersen J, Maro V, Kinabo G, et al.
Emerg Infect Dis
. 2024 Jul;
30(8):1599-1608.
PMID: 39043406
Bacterial zoonoses are established causes of severe febrile illness in East Africa. Within a fever etiology study, we applied a high-throughput 16S rRNA metagenomic assay validated for detecting bacterial zoonotic...
6.
Vlasiuk E, Zawari M, Storer M, Maze M, Williman J, Chambers S, et al.
Antioxidants (Basel)
. 2024 Mar;
13(3).
PMID: 38539806
Severe respiratory infections are characterised by depleted vitamin C and elevated inflammation and oxidative stress. The aim of this study was to recruit people with a history of severe respiratory...
7.
Moorthy G, Rubach M, Maze M, Refuerzo R, Shirima G, Lukambagire A, et al.
Trop Med Int Health
. 2024 Mar;
29(5):365-376.
PMID: 38480005
Background: In northern Tanzania, Q fever, spotted fever group (SFG) rickettsioses, and typhus group (TG) rickettsioses are common causes of febrile illness. We sought to describe the prevalence and risk...
8.
Hagedoorn N, Maze M, Carugati M, Cash-Goldwasser S, Allan K, Chen K, et al.
Trop Med Int Health
. 2024 Feb;
29(3):161-172.
PMID: 38351504
Objectives: Leptospira, the spirochaete causing leptospirosis, can be classified into >250 antigenically distinct serovars. Although knowledge of the animal host species and geographic distribution of Leptospira serovars is critical to...
9.
Morpeth S, Venkatesh B, Totterdell J, McPhee G, Mahar R, Jones M, et al.
NEJM Evid
. 2024 Feb;
2(11):EVIDoa2300132.
PMID: 38320527
BACKGROUND: Nafamostat mesylate is a potent in vitro antiviral agent that inhibits the host transmembrane protease serine 2 enzyme used by severe acute respiratory syndrome coronavirus 2 for cell entry....
10.
McQuilten Z, Venkatesh B, Jha V, Roberts J, Morpeth S, Totterdell J, et al.
NEJM Evid
. 2024 Feb;
2(2):EVIDoa2200293.
PMID: 38320033
BACKGROUND: Optimal thromboprophylaxis for hospitalized patients with coronavirus disease 2019 (Covid-19) is uncertain. METHODS: In an open-label, adaptive platform trial, we randomly assigned hospitalized adults with Covid-19 to low-dose low-molecular-weight...